Libra Infusions Limited (DSE:LIBRAINFU)

Libra Infusions Statistics

Total Valuation

Libra Infusions has a market cap or net worth of BDT 1.55 billion.

Market Cap	1.55B
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Libra Infusions has 2.25 million shares outstanding.

Current Share Class	2.25M
Shares Outstanding	2.25M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

The trailing PE ratio is 977.01.

PE Ratio	977.01
Forward PE	n/a
PS Ratio	7.86
PB Ratio	0.81
P/TBV Ratio	0.81
P/FCF Ratio	n/a
P/OCF Ratio	105.51
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.65, with a Debt / Equity ratio of 0.48.

Current Ratio	0.65
Quick Ratio	0.22
Debt / Equity	0.48
Debt / EBITDA	31.80
Debt / FCF	-174.68
Interest Coverage	0.97

Financial Efficiency

Return on equity (ROE) is 0.08% and return on invested capital (ROIC) is 0.49%.

Return on Equity (ROE)	0.08%
Return on Assets (ROA)	0.36%
Return on Invested Capital (ROIC)	0.49%
Return on Capital Employed (ROCE)	0.81%
Revenue Per Employee	281,876
Profits Per Employee	2,266
Employee Count	699
Asset Turnover	0.05
Inventory Turnover	1.59

Taxes

In the past 12 months, Libra Infusions has paid 674,316 in taxes.

Income Tax	674,316
Effective Tax Rate	29.86%

Stock Price Statistics

The stock price has decreased by -12.26% in the last 52 weeks. The beta is -0.39, so Libra Infusions's price volatility has been lower than the market average.

Beta (5Y)	-0.39
52-Week Price Change	-12.26%
50-Day Moving Average	759.31
200-Day Moving Average	788.01
Relative Strength Index (RSI)	35.08
Average Volume (20 Days)	5,044

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Libra Infusions had revenue of BDT 197.03 million and earned 1.58 million in profits. Earnings per share was 0.70.

Revenue	197.03M
Gross Profit	77.89M
Operating Income	22.22M
Pretax Income	2.26M
Net Income	1.58M
EBITDA	28.79M
EBIT	22.22M
Earnings Per Share (EPS)	0.70

Balance Sheet

The company has 14.39 million in cash and 915.38 million in debt, giving a net cash position of -901.00 million or -399.93 per share.

Cash & Cash Equivalents	14.39M
Total Debt	915.38M
Net Cash	-901.00M
Net Cash Per Share	-399.93
Equity (Book Value)	1.91B
Book Value Per Share	845.97
Working Capital	-104.18M

Cash Flow

In the last 12 months, operating cash flow was 14.67 million and capital expenditures -19.91 million, giving a free cash flow of -5.24 million.

Operating Cash Flow	14.67M
Capital Expenditures	-19.91M
Free Cash Flow	-5.24M
FCF Per Share	-2.33

Margins

Gross margin is 39.53%, with operating and profit margins of 11.28% and 0.80%.

Gross Margin	39.53%
Operating Margin	11.28%
Pretax Margin	1.15%
Profit Margin	0.80%
EBITDA Margin	14.61%
EBIT Margin	11.28%
FCF Margin	n/a

Dividends & Yields

Libra Infusions does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	0.58%
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	0.10%
FCF Yield	-0.34%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on December 27, 2023. It was a forward split with a ratio of 1.5.

Last Split Date	Dec 27, 2023
Split Type	Forward
Split Ratio	1.5

Scores

Libra Infusions has an Altman Z-Score of 0.79 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.79
Piotroski F-Score	5